TRCT
TROVW

Tower Research Capital (TRC)’s TrovaGene, Inc. Warrant TROVW Stock Holding History

Tower Research Capital (TRC)’s Portfolio TROVW Stock Details TROVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-362
Closed – – 4876
2016
Q3 		$0 Hold
362
– – ﹤0.01% 5111
2016
Q2 		$1K Hold
362
– – ﹤0.01% 4322
2016
Q1 		$1K Buy
362
+162
+81% +$525 ﹤0.01% 3949
2015
Q4 		$1K Buy
200
+157
+365% +$541 ﹤0.01% 4302
2015
Q3 		$0 Sell
43
-14
-25% -$73 ﹤0.01% 5307
2015
Q2 		$0 Sell
57
-93
-62% -$594 ﹤0.01% 5447
2015
Q1 		$1K Buy
150
+123
+456% +$467 ﹤0.01% 4260
2014
Q4 		$0 Hold
27
– – ﹤0.01% 5177
2014
Q3 		$0 Sell
27
-77
-74% -$225 ﹤0.01% 5218
2014
Q2 		$0 Sell
104
-91
-47% -$304 ﹤0.01% 5049
2014
Q1 		$1K Sell
195
-895
-82% -$3.81K ﹤0.01% 4291
2013
Q4 		$4K Buy
1,090
+1,015
+1,353% +$4.77K ﹤0.01% 3751
2013
Q3 		$0 Sell
75
-112
-60% -$641 ﹤0.01% 5066
2013
Q2 		$1K Buy
+187
New +$587 ﹤0.01% 3812

Other funds holding TROVW

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s TROVW Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of TrovaGene, Inc. Warrant (TROVW) in Q4 2016, closing a stake of 362 shares.

Tower Research Capital (TRC) first reported a position in TROVW in Q2 2013 and held it in 14 quarters. The position peaked at $4K in Q4 2013. 3 funds tracked by Wall St. Rank hold TROVW as of Q4 2016.

  • Tower Research Capital (TRC) reported no remaining TrovaGene, Inc. Warrant position as of Q4 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 362 TrovaGene, Inc. Warrant shares in Q4 2016.
  • Tower Research Capital (TRC) first reported a position in TrovaGene, Inc. Warrant in Q2 2013 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s TrovaGene, Inc. Warrant position peaked at $4K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held TrovaGene, Inc. Warrant as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.